Back to EBS
D. E. Shaw & Co., Inc. EBS Position History
Emergent BioSolutions Inc. • Healthcare
Quarters held
33
Latest value
$2M
Q2 2026
Peak value
$28.1M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $28.1M |
| Q2 2022 | $5M |
| Q3 2022 | $18.7M |
| Q3 2022 | $2.2M |
| Q4 2022 | $16M |
| Q4 2022 | $3.3M |
| Q1 2023 | $11.7M |
| Q1 2023 | $2.4M |
| Q2 2023 | $6M |
| Q2 2023 | $1.2M |
| Q3 2023 | $2.4M |
| Q3 2023 | $773K |
| Q4 2023 | $2.4M |
| Q4 2023 | $496K |
| Q1 2024 | $879K |
| Q1 2024 | $175K |
| Q2 2024 | $5.6M |
| Q3 2024 | $6.1M |
| Q3 2024 | $339K |
| Q4 2024 | $3.2M |
| Q4 2024 | $452K |
| Q1 2025 | $745K |
| Q1 2025 | $578K |
| Q2 2025 | $989K |
| Q2 2025 | $1.6M |
| Q3 2025 | $1.5M |
| Q3 2025 | $1.4M |
| Q4 2025 | $6.7M |
| Q4 2025 | $2.3M |
| Q1 2026 | $6.3M |
| Q1 2026 | $2.1M |
| Q2 2026 | $5.6M |
| Q2 2026 | $2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $2M | 235.1K | — | — |
| Q2 2026 | $5.6M | 665.0K | — | — |
| Q1 2026 | $2.1M | 250.5K | — | — |
| Q1 2026 | $6.3M | 753.5K | — | — |
| Q4 2025 | $2.3M | 184.0K | — | — |
| Q4 2025 | $6.7M | 539.3K | — | — |
| Q3 2025 | $1.4M | 156.6K | — | — |
| Q3 2025 | $1.5M | 164.6K | — | — |
| Q2 2025 | $1.6M | 256.4K | — | — |
| Q2 2025 | $989K | 155.0K | — | — |
| Q1 2025 | $578K | 119.0K | — | — |
| Q1 2025 | $745K | 153.3K | — | — |
| Q4 2024 | $452K | 47.3K | — | — |
| Q4 2024 | $3.2M | 335.7K | — | — |
| Q3 2024 | $339K | 40.5K | — | — |
| Q3 2024 | $6.1M | 730.6K | — | — |
| Q2 2024 | $5.6M | 827.8K | — | — |
| Q1 2024 | $175K | 69.3K | — | — |
| Q1 2024 | $879K | 347.4K | — | — |
| Q4 2023 | $496K | 206.5K | — | — |
| Q4 2023 | $2.4M | 980.0K | — | — |
| Q3 2023 | $773K | 227.4K | — | — |
| Q3 2023 | $2.4M | 709.2K | — | — |
| Q2 2023 | $1.2M | 163.9K | — | — |
| Q2 2023 | $6M | 814.0K | — | — |
| Q1 2023 | $2.4M | 230.7K | — | — |
| Q1 2023 | $11.7M | 1.13M | — | — |
| Q4 2022 | $3.3M | 279.5K | — | — |
| Q4 2022 | $16M | 1.35M | — | — |
| Q3 2022 | $2.2M | 103.5K | — | — |
| Q3 2022 | $18.7M | 888.7K | — | — |
| Q2 2022 | $5M | 159.5K | — | — |
| Q2 2022 | $28.1M | 906.4K | — | — |
Other funds holding EBS
$39.5M
$33.3M
$28.2M
$24.6M
$24.6M
$23.7M
$22.6M